IL-4 and IL-13 activate the JAK2 tyrosine kinase and Stat6 in cultured human vascular endothelial cells through a common pathway that does not involve the gamma c …

RL Palmer-Crocker, CC Hughes… - The Journal of clinical …, 1996 - Am Soc Clin Investig
RL Palmer-Crocker, CC Hughes, JS Pober
The Journal of clinical investigation, 1996Am Soc Clin Investig
IL-4 and IL-13 each act on human endothelial cells (ECs) to induce expression of vascular
cell adhesion molecule-1. On hematopoietic cells. IL-4 responses may be mediated either
through a pathway involving gc, the common signaling subunit of the IL-2, IL-4, IL-7, IL-9,
and IL-15 receptors, or through a gc-independent pathway that may be alternatively
activated by IL-13. We find that human ECs do not express gc, as detected by indirect
immunofluorescence and FACS analysis or by a reverse transcription-PCR method. Like IL …
IL-4 and IL-13 each act on human endothelial cells (ECs) to induce expression of vascular cell adhesion molecule-1. On hematopoietic cells. IL-4 responses may be mediated either through a pathway involving gc, the common signaling subunit of the IL-2, IL-4, IL-7, IL-9, and IL-15 receptors, or through a gc-independent pathway that may be alternatively activated by IL-13. We find that human ECs do not express gc, as detected by indirect immunofluorescence and FACS analysis or by a reverse transcription-PCR method. Like IL-4, IL-13 activates a protein tyrosine kinase that phosphorylates the IL-4R binding protein. In addition, we find that IL-4 and IL-13 each induce tyrosine phosphorylation of the JAK2 tyrosine kinase. Furthermore, both IL-4 and IL-13 induce binding of the Stat6 transcription factor to a consensus sequence oligonucleotide. We conclude that the IL-4 response of human ECs involves the IL-13 shared pathway that is independent of gc, and uses JAK2-Stat6 signaling.
The Journal of Clinical Investigation